Pulmonary aspergillosis: Recent advances

Medicine and Dentistry

• Combination Therapy 100%
• Therapeutic Procedure 100%
• Diseases 66%
• Immune Response 66%
• Invasive Aspergillosis 66%
• Morbidity 33%
• Antifungal Therapy 33%
• Antifungal Agent 33%
• Prophylaxis 33%
• Diagnosis 33%
• Aspergillosis 33%
• Lung Aspergillosis 33%
• Voriconazole 33%
• Infection 33%
• Granulocyte 33%
• Allergic Bronchopulmonary Aspergillosis 33%
• Mortality 33%
• Host 33%
• Patient 33%
• Inpatient 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Diseases 66%
• Invasive Aspergillosis 66%
• Aspergillosis 33%
• Lung Aspergillosis 33%
• Combination Therapy 33%
• Voriconazole 33%
• Morbidity 33%
• Infection 33%
• Allergic Bronchopulmonary Aspergillosis 33%
• Mortality 33%
• Host 33%